NJ’s Biopharma Sector in a Price Controlled World
In this Vital Health Podcast, we speak with Debbie Hart, President & CEO of BioNJ about the direct impacts of the Inflation Reduction Act upon her members. Under Debbie’s leadership, BioNJ has earned the reputation as the trusted voice of the life sciences industry in New Jersey. Most recently, she was named by Governor Murphy as the new Chair of the New Jersey Commission on Science, Innovation and Technology which supports innovation with grants and other programs.
According to the trade journal BioSpace, “New Jersey is one of the most important states in the U.S. pharmaceutical industry…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.